J. Verhoef

Questioning the use of PEGylation for drug delivery

J. Verhoef, Thomas J. Anchordoquy · Drug Delivery and Translational Research · 2013 · 336 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +12

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

Mariona Estapé Sentí, Caroline A. de Jongh, Kim Dijkxhoorn et al. · Journal of Controlled Release · 2021 · 177 citations · Full text

Life Sciences, Immunology, Pharmaceutics +17

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus

F.-J. Schmitz, Ad C. Fluit, Marc Lückefahr et al. · Journal of Antimicrobial Chemotherapy · 1998 · 160 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Polyphosphate nanoparticles on the platelet surface trigger contact system activation

J. Verhoef, Arjan D. Barendrecht, Katrin F. Nickel et al. · Blood · 2017 · 156 citations · Full text

Medicine, Biomedical Engineering, Materials Science +12

Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates

S. Nijssen, A. Florijn, Marc J. M. Bonten et al. · International Journal of Antimicrobial Agents · 2004 · 118 citations

Life Sciences, Infectious Diseases, Microbiology +14